<qa>  What is the STUDY OF PYROTINIB PLUS CAPECITABA STUDY OF PYROTINIB PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH HER2METASTATIC BREAST CANCER WHO HAVE PRIOR RECEIVED ANTHRACYCLIN, TAXANE OR TRASTUZUMAB: 